首页> 外文期刊>Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA >Bacterial DNA is associated with tunnel widening in failed ACL reconstructions
【24h】

Bacterial DNA is associated with tunnel widening in failed ACL reconstructions

机译:细菌DNA与ACL重建中失败的隧道扩展有关

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose To determine if tunnel widening, defined as change in maximal tunnel diameter from the time of initial bone tunnel drilling to revision surgery is associated with bacterial deoxyribonucleic acid (DNA) presence and concentration in torn graft tissue from failed anterior cruciate ligament reconstructions (ACLRs). Methods Thirty-four consecutive revision ACLRs were included (mean age 27.3 years SD 10.9; median time to failure 4.9 years range 105 days-20 years). Graft selection of the failed reconstruction was 68% autograft, 26% allograft, and 6% autograft/allograft hybrid with a mean drilled tunnel diameter of 8.4 mm SD 0.8. Maximal tunnel diameters prior to revision were measured on pre-operative three-dimensional imaging and compared to drilled tunnel diameters at the time of the previous reconstruction. Tissue biopsies of the failed graft were obtained from tibial, femoral, and intraarticular segments. Sterile water left open to air during revision ACLRs and tissue from primary ACLRs were used as negative controls. Clinical cultures were obtained on all revision ACLRs and PCR with universal bacterial primer on all cases and negative controls. Fluorescence microscopy was used to confirm the presence and location of biofilms in two patients with retrieved torn graft tissue and fixation material. Amount of tunnel widening was compared to bacterial DNA presence as well as bacterial DNA concentration via Welch ANOVA. Results Bacterial DNA was present in 29/34 (85%) revision ACLRs, 1/5 (20%) of primary ACLR controls and 0/3 (0%) sterile water controls. Cultures were positive (coagulase negative Staphylococcus sp.) in one case, which also had the greatest degree of tunnel widening. Femoral widening was greater in cases with detectable bacterial DNA (mean widening 2.6 mm SD 3.0) versus without (mean 0.3 mm SD 0.6) (p = 0.003) but was unaffected by bacterial DNA concentration (p = 0.44). Tibial widening was not associated with the presence of bacterial DNA (n.s.); however, higher bacterial DNA concentrations were observed in cases with tibial widening >= 3.0 mm (median 2.47 ng bacterial DNA/mu g total DNA) versus widening < 3.0 mm (median 0.97 ng bacterial DNA/mu g total DNA) (p = 0.046). Tunnel widening was not associated with time to failure, graft selection, or number of prior surgeries (n.s., all comparisons). Fluorescence microscopy confirmed the presence of biofilms on ruptured tendon graft as well as fixation material in 2/2 cases. Conclusion Bacterial DNA is commonly encountered on failed ACLR grafts and can form biofilms. Bacterial DNA does not cause clinically apparent infection symptoms but is associated with tunnel widening. Further research is needed to determine whether graft decontamination protocols can reduce graft bacterial colonization rates, ACLR tunnel widening or ACLR failure risk.
机译:目的是确定隧道扩大,定义为从初始骨隧道钻探到修订手术的最大隧道直径的变化与细菌脱氧核糖核酸(DNA)存在和浓度在撕裂的移植组织中,来自失效的前令韧带重建(ACLRS) 。方法包括三十四次连续修订ACLRS(平均年龄27.3岁,SD 10.9;失败的中位时间4.9岁的时间为105天 - 20年)。移植失败的重建选择是68%的自体移植物,26%的同种异体移植物和6%的自体移植/同种异体移植杂种,平均钻孔直径为8.4 mm SD 0.8。在预测前的三维成像之前测量修订前的最大隧道直径,与先前重建时的钻孔隧道直径相比。从胫骨,股骨头和外部段中获得失败移植物的组织活组织检查。在修订期间,在修改ACLR和原发性ACLR的组织中,无菌水用作阴性对照。在所有病例和阴性对照上用通用细菌底漆获得临床培养物。使用荧光显微镜检查两种患者中生物膜的存在和位置,检出的撕裂移植组织和固定材料。将隧道扩展的量与细菌DNA存在相比以及通过韦尔奇ANOVA的细菌DNA浓度。结果细菌DNA在29/34(85%)修订ACLR中,1/5(20%)的主要ACLR对照和0/3(0%)无菌水对照。在一种情况下,培养物是阳性(凝壳酶阴性葡萄球菌SP。),其中也具有最大程度的隧道加宽。在具有可检测的细菌DNA的情况下(平均扩展2.6mm SD 3.0)而不是(平均0.3mm SD 0.6)(p = 0.003)但未受细菌DNA浓度的情况(p = 0.44),股骨长较宽较大。胫骨长与细菌DNA(N.S)的存在无关;然而,在胫骨长扩展> = 3.0mm(中位数2.47ng细菌DNA / mu g总DNA的情况下,观察到更高的细菌DNA浓度)与加宽<3.0mm(中位数0.97ng细菌DNA / mu g总DNA)(p = 0.046 )。隧道扩展与失败,移植选择或先前手术的数量(N.S.,所有比较)无关。荧光显微镜证实了在破裂的肌腱移植物上存在生物膜以及2/2例中的固定材料。结论细菌DNA通常遇到在发生故障的ACLR移植物上,可以形成生物膜。细菌DNA不会引起临床表观性感染症状,但与隧道扩大有关。需要进一步研究以确定移植物去污方案是否可以减少接枝细菌定植率,ACLR隧道扩大或ACLR失效风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号